Aurora Cannabis (NYSE:ACB,TSX:ACB) announced that its Aurora River production facility in Bradford, Ontario, has received European Union Good Manufacturing Practice (EU GMP) certification.
As quoted in the press release:
EU GMP certification is granted to companies whose production facilities demonstrate a high degree of quality and consistency in their manufacturing procedures and is a requirement for the export of medical cannabis products into most European markets.
In addition, Aurora is pleased to announce it has received all necessary approvals from local regulators in Germany for sales of its medical cannabis products, following a temporary sales suspension on certain products in December 2019. Aurora will fulfill existing sales orders from inventory currently held in Germany, ensuring local patients will have immediate access to medicine from their preferred pharmacy.